Frederick Bauzon
Impact in
-
- Cancer-related Molecular Pathways
- Ophthalmology top 10%
- Ocular Oncology and Treatments
Papers in
- Oncology 8
- Cancer-related Molecular Pathways 8
-
- Ubiquitin and proteasome pathways 5
- Epigenetics and DNA Methylation 1
- Co-authors
- Liang Zhu (9 shared papers)Keiichi I. Nakayama (3 shared papers)Keiko Nakayama (3 shared papers)Joseph Locker (3 shared papers)Hao Fu (6 shared papers)Zhonglei Lu (6 shared papers)Jinhua Cui (5 shared papers)Hongling Zhao (5 shared papers)
- Journals
- Journal of Biological Chemistry (2 papers)Nature Communications (1 paper)Molecular Biology and Evolution (1 paper)Oncogene (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Frederick Bauzon
12 papers receiving 386 citations
Peers
Comparison fields: 5 of 51
- Oncology 175
- Ophthalmology 37
- Molecular Biology 250
- Cancer Research 34
- Cell Biology 39
Countries citing papers authored by Frederick Bauzon
This map shows the geographic impact of Frederick Bauzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Bauzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Bauzon more than expected).
Fields of papers citing papers by Frederick Bauzon
This network shows the impact of papers produced by Frederick Bauzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Bauzon. The network helps show where Frederick Bauzon may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick Bauzon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 96 | |
| 2 | 2013 | 63 | |
| 3 | 2005 | 62 | |
| 4 | 2014 | 38 | |
| 5 | 2012 | 30 | |
| 6 | 2016 | 24 | |
| 7 | 2014 | 20 | |
| 8 | 2013 | 18 | |
| 9 | 2015 | 12 | |
| 10 | 2010 | 10 | |
| 11 | 2016 | 9 | |
| 12 | 2007 | 5 |
About Frederick Bauzon
Frederick Bauzon is a scholar working on Oncology, Molecular Biology, Surgery, Cell Biology and Ophthalmology, having authored 12 papers that have together received 387 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Ubiquitin and proteasome pathways (5 papers), Microtubule and mitosis dynamics (3 papers), Ocular Oncology and Treatments (2 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper), Epigenetics and DNA Methylation (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Oncology (175 citations), Ophthalmology (37 citations), Molecular Biology (250 citations), Cancer Research (34 citations) and Cell Biology (39 citations). Frederick Bauzon has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Liang Zhu, Keiichi I. Nakayama, Keiko Nakayama, Joseph Locker, Hao Fu, Zhonglei Lu, Jinhua Cui, Hongling Zhao, Hongbo Wang and Peng Ji. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications, Molecular Biology and Evolution, Oncogene and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.